Covidien plc (NYSE: COV) will acquire Israel-based bronchial tubes endoscope maker superDimension Ltd. for about $300 million, the company announced in March. Ireland based-Covidien has annual sales of $30 million. SuperDimension’s i-Logic System uses Electromagnetic Navigation Bronchoscopy to provide minimally invasive access to lesions in the lungs and is mostly used to diagnose lung cancer.
Discover more from
Subscribe to get the latest posts sent to your email.
